141 related articles for article (PubMed ID: 35598460)
1. Specific metabolic response of patient-derived organoids to curcumin of colorectal cancer.
Chen L; Dai Z; Ge C; Huang D; Zhou X; Pan K; Xu W; Fu J; Du JL
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jul; 1203():123260. PubMed ID: 35598460
[TBL] [Abstract][Full Text] [Related]
2. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Xie BY; Wu AW
Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
[TBL] [Abstract][Full Text] [Related]
3. A combination of curcumin and oligomeric proanthocyanidins offer superior anti-tumorigenic properties in colorectal cancer.
Ravindranathan P; Pasham D; Balaji U; Cardenas J; Gu J; Toden S; Goel A
Sci Rep; 2018 Sep; 8(1):13869. PubMed ID: 30218018
[TBL] [Abstract][Full Text] [Related]
4. 3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids.
Schnalzger TE; de Groot MH; Zhang C; Mosa MH; Michels BE; Röder J; Darvishi T; Wels WS; Farin HF
EMBO J; 2019 Jun; 38(12):. PubMed ID: 31036555
[TBL] [Abstract][Full Text] [Related]
5. A growth factor-reduced culture system for colorectal cancer organoids.
Tan R; Zhang Z; Ding P; Liu Y; Liu H; Lu M; Chen YG
Cancer Lett; 2024 Apr; 588():216737. PubMed ID: 38382667
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of Using a Patient-Derived Tumor Organoid Culture Model to Predict the Response to Chemotherapy Regimens In Stage IV Colorectal Cancer: A Blinded Study.
Wang T; Pan W; Zheng H; Zheng H; Wang Z; Li JJ; Deng C; Yan J
Dis Colon Rectum; 2021 Jul; 64(7):833-850. PubMed ID: 33709991
[TBL] [Abstract][Full Text] [Related]
7. From organoids to bedside: Advances in modeling, decoding and targeting of colorectal cancer.
Betge J; Jackstadt R
Int J Cancer; 2023 Apr; 152(7):1304-1313. PubMed ID: 36121667
[TBL] [Abstract][Full Text] [Related]
8. Drug repurposing screening and mechanism analysis based on human colorectal cancer organoids.
Mao Y; Wang W; Yang J; Zhou X; Lu Y; Gao J; Wang X; Wen L; Fu W; Tang F
Protein Cell; 2024 Apr; 15(4):285-304. PubMed ID: 37345888
[TBL] [Abstract][Full Text] [Related]
9. Systematic evaluation of colorectal cancer organoid system by single-cell RNA-Seq analysis.
Wang R; Mao Y; Wang W; Zhou X; Wang W; Gao S; Li J; Wen L; Fu W; Tang F
Genome Biol; 2022 Apr; 23(1):106. PubMed ID: 35484598
[TBL] [Abstract][Full Text] [Related]
10. Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases.
Weeber F; van de Wetering M; Hoogstraat M; Dijkstra KK; Krijgsman O; Kuilman T; Gadellaa-van Hooijdonk CG; van der Velden DL; Peeper DS; Cuppen EP; Vries RG; Clevers H; Voest EE
Proc Natl Acad Sci U S A; 2015 Oct; 112(43):13308-11. PubMed ID: 26460009
[TBL] [Abstract][Full Text] [Related]
11. The drug-induced phenotypic landscape of colorectal cancer organoids.
Betge J; Rindtorff N; Sauer J; Rauscher B; Dingert C; Gaitantzi H; Herweck F; Srour-Mhanna K; Miersch T; Valentini E; Boonekamp KE; Hauber V; Gutting T; Frank L; Belle S; Gaiser T; Buchholz I; Jesenofsky R; Härtel N; Zhan T; Fischer B; Breitkopf-Heinlein K; Burgermeister E; Ebert MP; Boutros M
Nat Commun; 2022 Jun; 13(1):3135. PubMed ID: 35668108
[TBL] [Abstract][Full Text] [Related]
12. Organoid screening reveals epigenetic vulnerabilities in human colorectal cancer.
Toshimitsu K; Takano A; Fujii M; Togasaki K; Matano M; Takahashi S; Kanai T; Sato T
Nat Chem Biol; 2022 Jun; 18(6):605-614. PubMed ID: 35273398
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Drug Response Phenotyping in Colorectal Cancer Organoids by LC-QTOF-MS.
Neef SK; Janssen N; Winter S; Wallisch SK; Hofmann U; Dahlke MH; Schwab M; Mürdter TE; Haag M
Metabolites; 2020 Dec; 10(12):. PubMed ID: 33271860
[TBL] [Abstract][Full Text] [Related]
14. Acoustic Bioprinting of Patient-Derived Organoids for Predicting Cancer Therapy Responses.
Chen H; Wu Z; Gong Z; Xia Y; Li J; Du L; Zhang Y; Gao X; Fan Z; Hu H; Qian Q; Ding Z; Guo S
Adv Healthc Mater; 2022 Jul; 11(13):e2102784. PubMed ID: 35358375
[TBL] [Abstract][Full Text] [Related]
15. Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer.
Boos SL; Loevenich LP; Vosberg S; Engleitner T; Öllinger R; Kumbrink J; Rokavec M; Michl M; Greif PA; Jung A; Hermeking H; Neumann J; Kirchner T; Rad R; Jung P
Cell Mol Gastroenterol Hepatol; 2022; 13(2):517-540. PubMed ID: 34700030
[TBL] [Abstract][Full Text] [Related]
16. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.
Votanopoulos KI; Mazzocchi A; Sivakumar H; Forsythe S; Aleman J; Levine EA; Skardal A
Ann Surg Oncol; 2019 Jan; 26(1):139-147. PubMed ID: 30414038
[TBL] [Abstract][Full Text] [Related]
17. Nodal-induced L1CAM/CXCR4 subpopulation sustains tumor growth and metastasis in colorectal cancer derived organoids.
Cave DD; Hernando-Momblona X; Sevillano M; Minchiotti G; Lonardo E
Theranostics; 2021; 11(12):5686-5699. PubMed ID: 33897875
[No Abstract] [Full Text] [Related]
18. Image-based profiling and deep learning reveal morphological heterogeneity of colorectal cancer organoids.
Huang K; Li M; Li Q; Chen Z; Zhang Y; Gu Z
Comput Biol Med; 2024 May; 173():108322. PubMed ID: 38554658
[TBL] [Abstract][Full Text] [Related]
19. Oligomeric proanthocyanidins (OPCs) target cancer stem-like cells and suppress tumor organoid formation in colorectal cancer.
Toden S; Ravindranathan P; Gu J; Cardenas J; Yuchang M; Goel A
Sci Rep; 2018 Feb; 8(1):3335. PubMed ID: 29463813
[TBL] [Abstract][Full Text] [Related]
20. Specific Labeling of Stem Cell Activity in Human Colorectal Organoids Using an ASCL2-Responsive Minigene.
Oost KC; van Voorthuijsen L; Fumagalli A; Lindeboom RGH; Sprangers J; Omerzu M; Rodriguez-Colman MJ; Heinz MC; Verlaan-Klink I; Maurice MM; Burgering BMT; van Rheenen J; Vermeulen M; Snippert HJG
Cell Rep; 2018 Feb; 22(6):1600-1614. PubMed ID: 29425513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
